Matches in Wikidata for { <http://www.wikidata.org/entity/Q91701581> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q91701581 description "article scientifique publié en 2019" @default.
- Q91701581 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q91701581 description "scientific article published on 08 April 2019" @default.
- Q91701581 description "wetenschappelijk artikel" @default.
- Q91701581 description "наукова стаття, опублікована 8 квітня 2019" @default.
- Q91701581 name "Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of ≥150-300 cells/μL" @default.
- Q91701581 name "Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of ≥150-300 cells/μL" @default.
- Q91701581 type Item @default.
- Q91701581 label "Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of ≥150-300 cells/μL" @default.
- Q91701581 label "Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of ≥150-300 cells/μL" @default.
- Q91701581 prefLabel "Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of ≥150-300 cells/μL" @default.
- Q91701581 prefLabel "Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of ≥150-300 cells/μL" @default.
- Q91701581 P1433 Q91701581-8B17CB5D-9C81-4321-8649-A213DDC28DB8 @default.
- Q91701581 P1476 Q91701581-2CC05FC7-B68F-4D53-B1C3-1C3F1127F9B5 @default.
- Q91701581 P2093 Q91701581-36D4C1F1-539E-4CB3-8A04-38CB1FD479F2 @default.
- Q91701581 P2093 Q91701581-7D364B50-6FE0-4ED2-8D56-76C9691BFE13 @default.
- Q91701581 P2093 Q91701581-9B71819D-5E91-40AE-A773-526FEC4D383C @default.
- Q91701581 P304 Q91701581-0402265D-21AE-4817-AF2F-4EDD63A04E6B @default.
- Q91701581 P31 Q91701581-E505EF0A-56EF-4034-BD5A-17496E6E177E @default.
- Q91701581 P356 Q91701581-48D363F2-9419-4353-9C30-98AE1053F889 @default.
- Q91701581 P478 Q91701581-BCC24CF2-3CD5-441E-AB33-5D53B66C8011 @default.
- Q91701581 P577 Q91701581-B0C28647-488F-4529-B603-0A7FA4661F2F @default.
- Q91701581 P698 Q91701581-56AC4B18-9F5D-41A6-BC5A-1E99FBDC9D04 @default.
- Q91701581 P921 Q91701581-072A1FEA-50CC-4C56-BE13-59447E64C089 @default.
- Q91701581 P356 J.RMED.2019.04.008 @default.
- Q91701581 P698 31047111 @default.
- Q91701581 P1433 Q2659932 @default.
- Q91701581 P1476 "Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of ≥150-300 cells/μL" @default.
- Q91701581 P2093 "Eric S Bradford" @default.
- Q91701581 P2093 "Oliver N Keene" @default.
- Q91701581 P2093 "Steven W Yancey" @default.
- Q91701581 P304 "139-141" @default.
- Q91701581 P31 Q13442814 @default.
- Q91701581 P356 "10.1016/J.RMED.2019.04.008" @default.
- Q91701581 P478 "151" @default.
- Q91701581 P577 "2019-04-08T00:00:00Z" @default.
- Q91701581 P698 "31047111" @default.
- Q91701581 P921 Q35869 @default.